CHRU de Brest
Brest, 29609, France
NCT Number: NCT03126383
The AMISS study will characterize the features of muscle disease in patients with primary Sjogren's syndrome (pSS).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Brest, 29609, France
Muscle disease is associated with pSS, but this association is not well defined. The AMISS study, a retrospective observational multicentric study, will recruit patients with pSS and muscle involvement in order to characterize in details the features of this association (epidemiological aspects, clinical presentation, biological, radiological and histological findings, treatments and outcomes).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At diagnosis
Among the patients included in the AMISS study, we will assess the proportion of patients who fulfill the classification criteria for the different inflammatory myopathies.
University Hospital, Brest
Other
Characterization of Inflammatory Muscle Involvement in Patients With Primary Sjögren's Syndrome
Acronym: AMISS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03614299
Primary Sjögren Syndrome
Brest, France
View Trial DetailsNCT04093531
Primary Sjögren Syndrome
Rochester, New York, United States
View Trial DetailsNCT04960605
Dental Implant, Primary Sjögren Syndrome
View Trial DetailsNCT05670535
Arthritis, Arthritis, Rheumatoid
Ankara, Turkey (Türkiye)
View Trial Details